Denosumab to Get Quick FDA Action for Bone Mets
Posted on 17. Jul, 2010 by Dr. Ellis in News and Updates
The FDA has given priority review status to the RANK ligand inhibitor denosumab (Prolia) to reduce skeletal-related events in cancer patients with bone metastases, drug maker Amgen announced.
Read Full Article…
Possibly Related Blogs
Keep Rosiglitazone on the Market, FDA Panel Says
Posted on 14. Jul, 2010 by Dr. Ellis in News and Updates
GAITHERSBURG, Md. (MedPage Today) — An advisory panel voted 20-12 to recommend that the FDA allow rosiglitazone (Avandia) to stay on the market, but most panelists want to see the controversial diabetes drug carry tougher warnings on its label.
Read Full Article…
Possibly Related Blogs
Local Dentist Takes Patient Comfort to a Whole New Level with Technology
Posted on 18. Jun, 2010 by Dr. Ellis in News and Updates
June 15, 2010, Online Station LLC – Local Dentist Takes Patient Comfort to a Whole New Level with Technology
Read Full Article…
Possibly Related Blogs
Preterm Birth Issue Explored by House Panel
Posted on 13. May, 2010 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — Premature births appear to be associated with a mix of factors — including previous preterm birth, high blood pressure, and diabetes — but how those factors intertwine remains a mystery.
Read Full Article…
